Plus   Neg

Novartis Commits To Increase Patient Reach; Enhances Full Carbon Neutrality Target

Novartis said it has committed to increase patient reach with its strategic medicines by at least 200% by 2025, as part of its ambition to expand access to medicines in low- and middle-income countries or LMICs.

In addition, the company plans to increase patient reach of its global health flagship programs in Leprosy, Malaria, Chagas Disease and Sickle Cell Disease by at least 50% over the same time period.

The company estimates achievement of those targets to result in a potential reach of over 23 million patients across both initiatives.

The company said it also further strengthened its carbon neutrality target to aim for full carbon neutrality across its supply chain by 2030, in addition to its already stated target for carbon neutrality in its own operations by 2025.

In addition, Novartis said that it has collaborated with the African Union initiated Africa Medical Supplies Platform to support the supply of medicines from the Novartis COVID-19 Pandemic Response Portfolio. The portfolio of 15 medicines, including Dexamethasone, for symptomatic treatment of COVID-19 for LMICs was launched in July 2020 and is provided through Sandoz, the generics and biosimilar division of Novartis.

The company noted that it completed enrollment in CAN-COVID Phase III clinical trial, studying canakinumab in patients with COVID-19 pneumonia, with an expected readout in Q4 2020. Novartis also continues a Phase III clinical trial to evaluate the use of ruxolitinib in COVID-19 patients with a severe immune reaction.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Orca Bay Foods, LLC recalled about 4,450 pounds of Trader Joe's brand Gluten Free Battered Halibut products for undeclared wheat and milk allergens, according to a statement published by the U.S. Food and Drug Administration (FDA). The action was initiated after it was discovered that product containing Wheat and Milk was distributed in packaging. Lee Kun-hee, the Chairman of South Korean conglomerate Samsung Group, has died on October 25, at the age of 78. It was he who transformed Samsung into a South Korean behemoth, and the world's largest manufacturer of smartphones, televisions, and semiconductors. As per reports, Lee's only son Jae-yong, who currently serves as vice chairman of Samsung Electronics, is likely to take over Samsung. Toy and board game company Hasbro, Inc. (HAS) reported Monday net earnings attributable to Hasbro for the third quarter of $220.90 million or $1.61 per share, compared to pro forma net earnings of $216.5 million or $1.57 per share in the year-ago period. Excluding items, adjusted earnings for the...
Follow RTT